Sanofi (BKK:SANOFI80)

Market Cap	4.00T
Revenue (ttm)	1.75T
Net Income (ttm)	347.22B
Shares Out	n/a
EPS (ttm)	281.62
PE Ratio	11.53
Forward PE	10.62
Dividend	0.10 (3.08%)
Ex-Dividend Date	May 13, 2025

Volume	3,082
Average Volume	359,965
Open	3.360
Previous Close	3.360
Day's Range	3.360 - 3.360
52-Week Range	2.900 - 4.100
Beta	n/a
RSI	69.02
Earnings Date	Jan 29, 2026

About Sanofi

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; influenza, booster, meningitis, and travel and endemic vaccines, that includes hepati...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 82,878
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: SANOFI80

Financial Performance

In 2024, Sanofi's revenue was 44.29 billion, an increase of 7.73% compared to the previous year's 41.11 billion. Earnings were 5.56 billion, an increase of 2.96%.

Financial numbers in EUR